PARAGON 28 INC (FNA) Fundamental Analysis & Valuation
NYSE:FNA • US69913P1057
Current stock price
13.09 USD
0 (0%)
At close:
13.11 USD
+0.02 (+0.15%)
After Hours:
This FNA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. FNA Profitability Analysis
1.1 Basic Checks
- In the past year FNA has reported negative net income.
- FNA had a negative operating cash flow in the past year.
- FNA had negative earnings in 4 of the past 5 years.
- FNA had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -18.79%, FNA is in line with its industry, outperforming 52.36% of the companies in the same industry.
- Looking at the Return On Equity, with a value of -41.84%, FNA is in line with its industry, outperforming 53.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.79% | ||
| ROE | -41.84% | ||
| ROIC | N/A |
ROA(3y)-19.77%
ROA(5y)-12.48%
ROE(3y)-38.84%
ROE(5y)-23.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of FNA (74.75%) is better than 86.91% of its industry peers.
- FNA's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for FNA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.75% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.62%
GM growth 5Y-1.89%
2. FNA Health Analysis
2.1 Basic Checks
- FNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- FNA has more shares outstanding than it did 1 year ago.
- FNA has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, FNA has a worse debt to assets ratio.
2.2 Solvency
- FNA has an Altman-Z score of 4.18. This indicates that FNA is financially healthy and has little risk of bankruptcy at the moment.
- FNA has a better Altman-Z score (4.18) than 76.44% of its industry peers.
- A Debt/Equity ratio of 0.84 indicates that FNA is somewhat dependend on debt financing.
- FNA has a Debt to Equity ratio of 0.84. This is in the lower half of the industry: FNA underperforms 72.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.84 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.18 |
ROIC/WACCN/A
WACC9.36%
2.3 Liquidity
- FNA has a Current Ratio of 3.51. This indicates that FNA is financially healthy and has no problem in meeting its short term obligations.
- FNA has a better Current ratio (3.51) than 60.21% of its industry peers.
- A Quick Ratio of 1.64 indicates that FNA should not have too much problems paying its short term obligations.
- FNA has a Quick ratio (1.64) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.51 | ||
| Quick Ratio | 1.64 |
3. FNA Growth Analysis
3.1 Past
- FNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.53%.
- The Revenue has grown by 18.39% in the past year. This is quite good.
- FNA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.23% yearly.
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)18.39%
Revenue growth 3Y20.2%
Revenue growth 5Y19.23%
Sales Q2Q%18.47%
3.2 Future
- The Earnings Per Share is expected to grow by 8.91% on average over the next years. This is quite good.
- Based on estimates for the next years, FNA will show a quite strong growth in Revenue. The Revenue will grow by 18.63% on average per year.
EPS Next Y25.22%
EPS Next 2Y21.57%
EPS Next 3Y6.22%
EPS Next 5Y8.91%
Revenue Next Year14.16%
Revenue Next 2Y14.04%
Revenue Next 3Y18.74%
Revenue Next 5Y18.63%
3.3 Evolution
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. FNA Valuation Analysis
4.1 Price/Earnings Ratio
- FNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FNA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.57%
EPS Next 3Y6.22%
5. FNA Dividend Analysis
5.1 Amount
- No dividends for FNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FNA Fundamentals: All Metrics, Ratios and Statistics
13.09
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)05-08 2025-05-08/amc
Inst Owners56.68%
Inst Owner Change0%
Ins Owners15.11%
Ins Owner Change0%
Market Cap1.10B
Revenue(TTM)256.18M
Net Income(TTM)-54.64M
Analysts72
Price Target14.28 (9.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.65%
Min EPS beat(2)-6.82%
Max EPS beat(2)5.52%
EPS beat(4)2
Avg EPS beat(4)-11.35%
Min EPS beat(4)-44.11%
Max EPS beat(4)5.52%
EPS beat(8)3
Avg EPS beat(8)-27.56%
EPS beat(12)3
Avg EPS beat(12)-39.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.09%
Min Revenue beat(2)0.3%
Max Revenue beat(2)1.87%
Revenue beat(4)4
Avg Revenue beat(4)1.03%
Min Revenue beat(4)0.3%
Max Revenue beat(4)1.87%
Revenue beat(8)7
Avg Revenue beat(8)0.91%
Revenue beat(12)11
Avg Revenue beat(12)2.45%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.1%
EPS NY rev (1m)0%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.29 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 8.41 | ||
| P/tB | 12.96 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS3.05
BVpS1.56
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -18.79% | ||
| ROE | -41.84% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.75% | ||
| FCFM | N/A |
ROA(3y)-19.77%
ROA(5y)-12.48%
ROE(3y)-38.84%
ROE(5y)-23.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.62%
GM growth 5Y-1.89%
F-Score2
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.84 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 91.39% | ||
| Cap/Sales | 6.62% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.51 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4.18 |
F-Score2
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)195.19%
Cap/Depr(5y)198.62%
Cap/Sales(3y)14.44%
Cap/Sales(5y)13.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
EPS Next Y25.22%
EPS Next 2Y21.57%
EPS Next 3Y6.22%
EPS Next 5Y8.91%
Revenue 1Y (TTM)18.39%
Revenue growth 3Y20.2%
Revenue growth 5Y19.23%
Sales Q2Q%18.47%
Revenue Next Year14.16%
Revenue Next 2Y14.04%
Revenue Next 3Y18.74%
Revenue Next 5Y18.63%
EBIT growth 1Y-9.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year112.67%
EBIT Next 3Y35.33%
EBIT Next 5Y30.86%
FCF growth 1Y52.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.51%
OCF growth 3YN/A
OCF growth 5YN/A
PARAGON 28 INC / FNA Fundamental Analysis FAQ
What is the fundamental rating for FNA stock?
ChartMill assigns a fundamental rating of 3 / 10 to FNA.
What is the valuation status for FNA stock?
ChartMill assigns a valuation rating of 0 / 10 to PARAGON 28 INC (FNA). This can be considered as Overvalued.
How profitable is PARAGON 28 INC (FNA) stock?
PARAGON 28 INC (FNA) has a profitability rating of 1 / 10.
How financially healthy is PARAGON 28 INC?
The financial health rating of PARAGON 28 INC (FNA) is 4 / 10.